|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
ocn925411014 |
| 003 |
OCoLC |
| 005 |
20250225213021.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
151015s2016 enk ob 001 0 eng |
| 010 |
|
|
|a 2015040477
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d YDX
|d N$T
|d YDXCP
|d EBLCP
|d DG1
|d OCLCF
|d OCL
|d COO
|d KSU
|d DG1
|d CHVBK
|d UAB
|d OCLCO
|d MERER
|d OCLCO
|d LIP
|d CCO
|d K6U
|d LOA
|d COCUF
|d MERUC
|d ZCU
|d ICG
|d CNNOR
|d OCLCQ
|d D6H
|d OCLCQ
|d OCLCO
|d CASUM
|d OCLCO
|d CUY
|d WRM
|d STF
|d OCLCQ
|d VT2
|d AU@
|d OCLCO
|d OCLCQ
|d WYU
|d OCLCO
|d G3B
|d LVT
|d S8J
|d S9I
|d TKN
|d U3W
|d OCLCO
|d OCLCQ
|d OCLCO
|d DKC
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCL
|d INARC
|d OCLCO
|d OCLCL
|d CLOUD
|d OCLCQ
|
| 019 |
|
|
|a 981544095
|a 1104680879
|a 1228553755
|
| 020 |
|
|
|a 9781118949771
|q (ePub)
|
| 020 |
|
|
|a 1118949773
|q (ePub)
|
| 020 |
|
|
|a 9781118949764
|q (Adobe PDF)
|
| 020 |
|
|
|a 1118949765
|q (Adobe PDF)
|
| 020 |
|
|
|a 9781118949740
|
| 020 |
|
|
|a 1118949749
|
| 020 |
|
|
|a 1118949781
|q (cloth)
|
| 020 |
|
|
|a 9781118949788
|q (cloth)
|
| 020 |
|
|
|z 9781118949788
|q (cloth)
|
| 035 |
|
|
|a (OCoLC)925411014
|z (OCoLC)981544095
|z (OCoLC)1104680879
|z (OCoLC)1228553755
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RM301.25
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 049 |
|
|
|a HCDD
|
| 245 |
0 |
0 |
|a Drug utilization research :
|b methods and applications /
|c editors, Monique Elseviers [and 12 others].
|
| 264 |
|
1 |
|a Chichester, West Sussex ;
|a Hoboken, NJ :
|b John Wiley & Sons Inc.,
|c 2016.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a Title Page -- Copyright -- List of contributors -- Acknowledgements -- Advisory board -- Reviewers -- About the companion website -- Part 1: Introduction -- Chapter 1: Introduction to drug utilization research -- Room for improvement in drug utilization -- The history of drug utilization research -- Definition and delineation -- Skills needed to be a drug utilization researcher -- Areas of inquiry in drug utilization research reflected in this book -- Part 2: Methodology -- Chapter 2: Study designs in drug utilization research -- Introduction -- Quantitative and qualitative research.
|
| 505 |
8 |
|
|a Observational studies: from descriptive to analytical approaches -- Study designs for descriptive drug utilization studies -- Study designs for analytical drug utilization studies -- Experimental and quasiexperimental study designs in drug utilization research -- Other study designs for drug utilization research -- Chapter 3: Primary data collection for drug utilization research -- Introduction -- Identifying primary data sources for drug utilization research -- Collecting valuable primary data in drug utilization research.
|
| 505 |
8 |
|
|a Instruments and forms for primary data collection in drug utilization research -- Modes of primary data collection for drug utilization research -- Ethical considerations -- Conclusion -- Chapter 4: Secondary data sources for drug utilization research -- Introduction -- Sales data -- Electronic health records -- Pharmacy dispensing data -- Reimbursement data -- Patient registries -- Secondary analysis of population health survey data -- Record linkage in drug utilization research -- Privacy, confidentiality and security -- Data quality -- Chapter 5: Classification systems for drugs and diseases.
|
| 505 |
8 |
|
|a Introduction -- ATC -- Other drug classification systems -- Other classification systems relevant for drug utilization research -- Linkage of classification systems -- Chapter 6: Measurement units of drug utilization -- Introduction -- DDD: definition and general considerations -- Principles of DDD assignment -- Alterations and misuse of DDDs -- Other aggregate measures for prescribing -- Other drug utilization metrics -- Use of drugs in animals -- How to report aggregated drug use -- DDDs for special population groups -- Chapter 7: Individual-level drug utilization analyses -- Introduction.
|
| 505 |
8 |
|
|a General principles -- Epidemiological measures -- Other measures -- Strengths and limitations of individual-level statistics -- Chapter 8: Measurement of drug expenditure -- Introduction -- Definitions and perspectives -- Price-related units of pharmaceutical expenditure -- Methodological challenges related to pharmaceutical expenditure -- Chapter 9: Basic statistical methods in drug utilization research -- Introduction -- Why we need statistical methods in drug utilization and health services research -- Use of population data versus sample data -- Types of variables.
|
| 520 |
|
|
|a Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes. The discipline is closely related and linked mainly to the broader field of pharmacoepidemiology, but also to health outcomes research, pharmacovigilance and health economics. Drug Utilization Research is a unique, practical guide to the assessment and evaluation of prescribing practices and to interventions to improve the use of medicines in populations. Edited by an international expert team from the International Society for Pharmacoepidemiology (ISPE), DUR is the only title to cover both the methodology and applications of drug utilization research and covers areas such as health policy, specific populations, therapeutics and adherence.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a Drug utilization.
|
| 650 |
|
0 |
|a Medicine
|x Research.
|
| 650 |
|
0 |
|a Medical policy.
|
| 650 |
|
0 |
|a Drugs
|x Side effects
|x Reporting.
|
| 650 |
|
0 |
|a Drug monitoring.
|
| 650 |
|
0 |
|a Pharmacovigilance.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Pharmacology.
|2 bisacsh/2022
|
| 650 |
|
7 |
|a MEDICAL.
|2 bisacsh/2022
|
| 650 |
|
7 |
|a Pharmacovigilance
|2 fast
|
| 650 |
|
7 |
|a Medical policy
|2 fast
|
| 650 |
|
7 |
|a Drugs
|x Side effects
|x Reporting
|2 fast
|
| 650 |
|
7 |
|a Drug monitoring
|2 fast
|
| 650 |
|
7 |
|a Drug utilization
|2 fast
|
| 650 |
|
7 |
|a Drug development
|2 fast
|
| 650 |
|
7 |
|a Medicine
|x Research
|2 fast
|
| 700 |
1 |
|
|a Elseviers, Monique,
|e editor.
|
| 758 |
|
|
|i has work:
|a Drug Utilization Research (Text)
|1 https://id.oclc.org/worldcat/entity/E39PD3wF3hYGpx9F6YgjBJKhMd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|t Drug utilization research.
|d Chichester, West Sussex : Hoboken, NJ : John Wiley & Sons Inc., 2016
|z 9781118949788
|w (DLC) 2015039626
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=4462519
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|